Two vitamin C manufacturers based in China are reportedly arguing in a New York court that their government is responsible for their price-fixing. A class-action suit has been filed in US District Court in New York accusing two vitamin C companies of raising prices between December 2001 and June 2006. The media are reporting that the defendants will use the foreign sovereign compulsion doctrine defense, a rare argument that claims companies that break US law are protected if their own governments coerced the companies into that legal violation. The defense is seldom successful, say experts. Jury selection was scheduled for Monday.
Featured News
Apple Opens Early Settlement Discussions With DOJ
Jul 17, 2026 by
CPI
South Korean Steelmaker POSCO Expands Supplier Support Pact With Antitrust Regulator
Jul 16, 2026 by
CPI
FCC’s Carr Criticizes California-Led Bid to Block Paramount-Warner Bros. Discovery Deal
Jul 16, 2026 by
CPI
EU Top Court Upholds Antitrust Powers to Seize Corporate Emails
Jul 16, 2026 by
CPI
Uber Launches $14.8 Billion Bid for Delivery Hero in Landmark Food Delivery Deal
Jul 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Agentic AI & Antitrust
Jul 16, 2026 by
CPI
AI Agents and Collusion: The Two Faces of Agentic AI
Jul 16, 2026 by
Giovanna Massarotto
Agentic AI’s Regulatory Conundrum
Jul 16, 2026 by
Anant Raut
Inter-AI-Agent Competition
Jul 16, 2026 by
Stefan Thomas
Navigating the Increasing Regulatory Scrutiny of AI-Pricing Tools: Competition and Other Emerging Risks
Jul 16, 2026 by
Mark Krotoski & Vinny Sidhu